Long-term potentiation (LTP) and long-term depression (LTD) of hippocampal synaptic transmission represent the principal experimental models underlying learning and memory. Alterations of synaptic plasticity are observed in several neurodegenerative disorders, including Alzheimer's disease (AD). Indeed, synaptic dysfunction is an early event in AD, making it an attractive therapeutic target for pharmaceutical intervention. To date, intensive investigations have characterized hippocampal synaptic transmission, LTP, and LTD in in vitro and in murine models of AD. In this review, we describe the synaptic alterations across the main AD models generated so far. We then examine the clinical perspective of LTP/LTD studies and discuss the limitations of non-clinical models and how to improve their predictive validity in the drug discovery process.

Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease / Mango, Dalila; Saidi, Amira; Cisale, Giusy Ylenia; Feligioni, Marco; Corbo, Massimo; Nisticò, Robert. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 10:(2019), p. 778. [10.3389/fphar.2019.00778]

Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease

Mango, Dalila;SAIDI, AMIRA;Cisale, Giusy Ylenia;Nisticò, Robert
2019

Abstract

Long-term potentiation (LTP) and long-term depression (LTD) of hippocampal synaptic transmission represent the principal experimental models underlying learning and memory. Alterations of synaptic plasticity are observed in several neurodegenerative disorders, including Alzheimer's disease (AD). Indeed, synaptic dysfunction is an early event in AD, making it an attractive therapeutic target for pharmaceutical intervention. To date, intensive investigations have characterized hippocampal synaptic transmission, LTP, and LTD in in vitro and in murine models of AD. In this review, we describe the synaptic alterations across the main AD models generated so far. We then examine the clinical perspective of LTP/LTD studies and discuss the limitations of non-clinical models and how to improve their predictive validity in the drug discovery process.
2019
Alzheimer’s disease; long-term depression; long-term potentiation; predictive validity; synaptic plasticity
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Targeting Synaptic Plasticity in Experimental Models of Alzheimer's Disease / Mango, Dalila; Saidi, Amira; Cisale, Giusy Ylenia; Feligioni, Marco; Corbo, Massimo; Nisticò, Robert. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 10:(2019), p. 778. [10.3389/fphar.2019.00778]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1336057
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 55
social impact